Preparation of Nanofat Concentrate and Its Use for Hypertrophic Scar Treatment
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2022, Vol 3, Issue 2
Abstract
Objective: Nanofat grafting has been reported to improve tissue repair by the Stromal Vascular Fraction (SVF) of nanofat. However, the oil and liquid portions of fat tissues were released by mechanical emulsification during the nanofat procedure. Here, we reported a simple method to remove the oil and water for concentrating nanofat. Methods: The concentrate of nanofat was obtained by processing nanofat using negative pressure produced by syringer and two-step centrifugation. The volume of oil and fat tissue as well as morphological changes of nanofat concetrate obtained by different procedures was examined. Meanwhile, the SVF numbers, the proliferation and differentiation capacity of Adipose-Derived Stem Cells (ADSCs) were determined. The clinical outcome of nanofat concentrate in treatment hypertrophic scar was evaluated. Results: The centrifugation and negative pressure had no significant effect on the proliferation activity of the SVF in the concentrate of nanofat. The concentrated rate after 0, 15, 30 and 60 times of emulsification was 2.08±0.042, 2.63 ± 0.07, 3.8 ± 0.01 and 8.2 ± 0.12 times greater than the original, respectively. The SVF number per 10 ml of fat in the above-mentioned groups were increased by 1.80 ± 0.15, 2.68 ± 0.27, 4.64 ± 0.20 and 3.44 ± 0.27 times, respectively. The capacity of cell proliferation and differentiation decreased significantly after more than 30 times emulsification. The concentrates of nanofat effectively improve the appearence and hardness of hypertrophic scar. Conclusion: The nanofat concentrate prepared by our method include more SVF cells and less oil and might be more effective during clinical use.
Authors and Affiliations
Sheng-Hong Li1, Yin-Di Wu1, Ze-Hua Li1, Xiao Jiang1, Xuan Liao1, Guang-Hui Xie1, Li-Ling Xiao1, Ting Wan2, Hai-Ling Huang1, Hong-Wei Liu1*
Keywords
Related Articles
- EP ID EP703280
- DOI https://doi.org/10.46889/JRMBR.2022.3203
- Views 46
- Downloads 0
Local Anesthetics Can Affect the Efficacy of Telomerase-Positive Stem Cells
Early clinical studies with telomerase-positive stem cells demonstrated no response when these stem cells were mixed with lidocaine prior to clinical treatments in multiple individuals. Their stem cells demonstrated a...
Use of Stem Cells to Treat Left Ventricular Hypertrophy
Left Ventricular Hypertrophy is a multifactorial condition involving genetic and signaling pathways. Current recommendations for treating hypertensive LVH include ACE inhibitors, RAS and CCBs. Despite numerous drug thera...
Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-I
Mesenchymal stem cells hold many therapeutic benefits in treating diverse disease states, but autologous requirements, high costs, lack of standardization and other factors limit their widespread application. Additionall...
Potential Mesenchymal and Dental Pulp Stem Cell Usage for Regeneration of Dentine and Its Complications
Tooth decay is an extremely common problem throughout the nation. As individuals pass the age of 20 years old, 90% have had some form of tooth decay. Along with this, more than 1 in 4 people have untreated tooth decay in...
Longitudinal Assessment of FEV1 Change Following Autologous Cellular Therapy
Objective: Current pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) is aimed at improving symptoms and preventing exacerbations, yet none can alter the natural progression of lung function decli...